Celularity Pretax Profit Margin from 2010 to 2024
| CELU Stock | USD 3.29 0.17 5.45% |
Pretax Profit Margin | First Reported 2010-12-31 | Previous Quarter 0.71 | Current Value 0.75 | Quarterly Volatility 4.08408005 |
Check Celularity financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Celularity main balance sheet or income statement drivers, such as Interest Expense of 2.5 M, Net Income Applicable To Common Shares of 17.1 M or Income Tax Expense of 15.7 K, as well as many exotic indicators such as Price To Sales Ratio of 15.57, Dividend Yield of 0.0 or PTB Ratio of 1.06. Celularity financial statements analysis is a perfect complement when working with Celularity Valuation or Volatility modules.
Celularity | Pretax Profit Margin |
Latest Celularity's Pretax Profit Margin Growth Pattern
Below is the plot of the Pretax Profit Margin of Celularity over the last few years. It is Celularity's Pretax Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Celularity's overall financial position and show how it may be relating to other accounts over time.
| Pretax Profit Margin | 10 Years Trend |
|
Pretax Profit Margin |
| Timeline |
Celularity Pretax Profit Margin Regression Statistics
| Arithmetic Mean | (0.95) | |
| Geometric Mean | 0.57 | |
| Coefficient Of Variation | (429.64) | |
| Mean Deviation | 2.36 | |
| Median | 0.31 | |
| Standard Deviation | 4.08 | |
| Sample Variance | 16.68 | |
| Range | 15.7036 | |
| R-Value | (0.23) | |
| Mean Square Error | 17.05 | |
| R-Squared | 0.05 | |
| Significance | 0.42 | |
| Slope | (0.21) | |
| Total Sum of Squares | 233.52 |
Celularity Pretax Profit Margin History
About Celularity Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Celularity income statement, its balance sheet, and the statement of cash flows. Celularity investors use historical funamental indicators, such as Celularity's Pretax Profit Margin, to determine how well the company is positioned to perform in the future. Although Celularity investors may use each financial statement separately, they are all related. The changes in Celularity's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Celularity's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Celularity Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Celularity. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | 0.71 | 0.75 |
Pair Trading with Celularity
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Celularity position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Celularity will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Celularity could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Celularity when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Celularity - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Celularity to buy it.
The correlation of Celularity is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Celularity moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Celularity moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Celularity can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Celularity Correlation against competitors. For more information on how to buy Celularity Stock please use our How to Invest in Celularity guide.You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Complementary Tools for Celularity Stock analysis
When running Celularity's price analysis, check to measure Celularity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celularity is operating at the current time. Most of Celularity's value examination focuses on studying past and present price action to predict the probability of Celularity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celularity's price. Additionally, you may evaluate how the addition of Celularity to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |
Is Celularity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Celularity. If investors know Celularity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Celularity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.93) | Earnings Share (10.30) | Revenue Per Share 0.887 | Quarterly Revenue Growth (0.08) | Return On Assets (0.20) |
The market value of Celularity is measured differently than its book value, which is the value of Celularity that is recorded on the company's balance sheet. Investors also form their own opinion of Celularity's value that differs from its market value or its book value, called intrinsic value, which is Celularity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Celularity's market value can be influenced by many factors that don't directly affect Celularity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Celularity's value and its price as these two are different measures arrived at by different means. Investors typically determine if Celularity is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Celularity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.